Radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products reported strong sales during its 2010 fiscal year.
Based on preliminary unaudited figures, Eckert & Ziegler recorded gross sales of 111 million euros ($154.6 million U.S.), representing growth of 9%. The firm's net income was 9.4 million euros ($13.1 million U.S.); excluding a one-time charge, net income was 10.1 million euros ($14.1 million U.S.).
